Genome-wide association studies (GWAS) have identified multiple single nucleotide
polymorphisms (SNPs) or small indels robustly associated with schizophrenia; however, the …

Background Genome-wide association studies (GWASs) have reported hundreds of
genomic loci associated with schizophrenia, yet identifying the functional risk variations is a …

Recent large-scale genome-wide association studies (GWAS) have enabled the discovery
of common genetic variations contributing to risk architectures of schizophrenia in human …

Schizophrenia is a common disorder with a high heritability, but its genetic architecture is
still elusive. We implemented whole-genome sequencing (WGS) analysis of 8 families with …

Genome-wide association studies (GWAS) have identified a large number of schizophrenia
risk variants, and most of them are mapped to noncoding regions. By leveraging multiple …

Background Over 200 schizophrenia risk loci have been identified by genome-wide
association studies (GWASs). However, the majority of risk loci were identified in …

Genome-wide association studies (GWASs) have successfully identified 145 genomic
regions that contribute to schizophrenia risk, but linkage disequilibrium makes it challenging …

Schizophrenia is a severe mental disorder affecting∼ 1% of the world population, with
heritability of up to 80%. To identify new common genetic risk factors, we performed a …

Many schizophrenia susceptibility loci have been identified through genome-wide
association studies (GWASs) in European populations. However, until recently …

Genome-wide association studies have identified multiple risk variants and loci that show
robust association with schizophrenia. Nevertheless, it remains unclear how these variants …